Equities

Sellas Life Sciences Group Inc

Sellas Life Sciences Group Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.18
  • Today's Change-0.01 / -0.84%
  • Shares traded683.79k
  • 1 Year change+21.64%
  • Beta2.3933
Data delayed at least 15 minutes, as of Oct 31 2024 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Sellas Life Sciences Group Inc (SLS:NAQ) closed at 1.18, -31.40% below its 52-week high of 1.72, set on Apr 23, 2024.
52-week range
Today
0.4986Jan 26 20241.72Apr 23 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open1.20
High1.21
Low1.14
Bid1.17
Offer1.18
Previous close1.19
Average volume689.59k
Shares outstanding64.33m
Free float64.18m
P/E (TTM)--
Market cap76.56m USD
EPS (TTM)-0.934
USD
Data delayed at least 15 minutes, as of Oct 31 2024 20:00 BST.
More ▼

Events & Activity

  • SLS:NAQ price falls below 200-day moving average to 1.18 at 09:41 BST
  • SLS:NAQ price falls below 200-day moving average to 1.17 at 14:37 BST
  • SLS:NAQ price moved over -1.63% to 1.21
  • SLS:NAQ price rises above 15-day moving average to 1.21 at 09:35 BST
  • SLS:NAQ price falls below 15-day moving average to 1.21 at 12:33 BST
  • SLS:NAQ price falls below 15-day moving average to 1.20 at 09:33 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.